Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Why classify basal cell carcinomas?

J J Rippey1

  • 1Western Australian Centre for Pathology and Medical Research, Queen Elizabeth II Medical Centre, Nedlands, Australia.

Histopathology
|June 25, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A striking incident: cutaneous actinomycosis following punch injury to the hand.

The Medical journal of Australia·1998
Same author

Characteristics of incompletely excised basal cell carcinomas of the skin.

The Medical journal of Australia·1997
Same author

More about counting mitoses.

Human pathology·1996
Same author

Standardisation of histopathology reports.

Journal of clinical pathology·1996
Same author

Counting mitoses.

Human pathology·1995
Same author

The pathology of Marburg virus disease.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·1984
Same journal

TROP2 immunoreactivity in pulmonary large cell neuroendocrine carcinoma.

Histopathology·2026
Same journal

Malignant adenomyoepithelioma of the breast: seven cases illustrating morphological diversity and diagnostic challenges.

Histopathology·2026
Same journal

A CRX-positive RB1-deficient bone tumour with a retinoblastoma-like DNA methylation profile.

Histopathology·2026
Same journal

Perivascular epithelioid cell tumours of the genitourinary tract: clinicopathological features and molecular landscape.

Histopathology·2026
Same journal

Navigating diagnostic challenges in low-grade spindle cell lesions of the breast: a retrospective review.

Histopathology·2026
Same journal

Neoplastic transformation of sporadic gastric hyperplastic polyps: a systematic review and meta-analysis of risk factors and clinicopathological features.

Histopathology·2026
See all related articles

Basal cell carcinoma (BCC), the most common skin cancer in fair-skinned individuals, can be pathologically classified by growth pattern. This classification aids clinicians in managing BCC and predicting recurrence risk after surgical excision.

Area of Science:

  • Dermatology
  • Oncology
  • Pathology

Background:

  • Basal cell carcinoma (BCC) is the most prevalent cancer in the white population.
  • Effective clinical management of BCC relies on accurate pathological assessment.
  • Understanding histological growth patterns is crucial for treatment planning.

Purpose of the Study:

  • To present a simple pathological classification for basal cell carcinoma.
  • To recommend this classification for routine clinical use.
  • To correlate histological growth patterns with treatment outcomes.

Main Methods:

  • Classification of BCC based on histological growth patterns.
  • Identification of nodular, infiltrative, superficial multifocal, and mixed patterns.
  • Correlation of these patterns with surgical excision success and recurrence rates.

Related Experiment Videos

Main Results:

  • Basal cell carcinoma exhibits distinct histological growth patterns: nodular, infiltrative, superficial multifocal, and mixed.
  • These patterns influence the likelihood of achieving complete surgical excision.
  • Incomplete excision is linked to a higher frequency of BCC recurrence.

Conclusions:

  • A simple pathological classification of BCC by growth pattern is proposed.
  • This classification system can assist clinicians in managing BCC cases.
  • Histological growth patterns are predictive of treatment success and recurrence risk.